comparemela.com
Latest Breaking News On - Stanford clinical research group - Page 1 : comparemela.com
Early Data for CRX100 Pave Way for Potential Combinations in Recurrent, Platinum-Resistant Ovarian Cancer
Oliver Dorigo, MD, PhD, discusses the investigation of CRX100 in patients with recurrent, platinum-resistant ovarian cancer.
Stanford
California
United-states
Oliver-dorigo
Mary-lake-polan-gynecologic-oncology-research-laboratory
Division-of-gynecologic-oncology
Stanford-gynecologic-oncology-clinical-care-program
Stanford-gynecologic-oncology-fellowship
Stanford-clinical-research-group
Gynecologic-cancer-trials
Stanford-obstetrics
Gynecologic-oncology
vimarsana © 2020. All Rights Reserved.